PT2970948T - Métodos de purificação de arn - Google Patents

Métodos de purificação de arn

Info

Publication number
PT2970948T
PT2970948T PT14709704T PT14709704T PT2970948T PT 2970948 T PT2970948 T PT 2970948T PT 14709704 T PT14709704 T PT 14709704T PT 14709704 T PT14709704 T PT 14709704T PT 2970948 T PT2970948 T PT 2970948T
Authority
PT
Portugal
Prior art keywords
purification methods
rna purification
rna
methods
purification
Prior art date
Application number
PT14709704T
Other languages
English (en)
Inventor
Berlanda Scorza Francesco
Wen Yingxia
Geall Andrew
Porter Frederick
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of PT2970948T publication Critical patent/PT2970948T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3847Multimodal interactions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
    • C12N15/101Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by chromatography, e.g. electrophoresis, ion-exchange, reverse phase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1017Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D2015/3838Ligand exchange chromatography, e.g. complexation chromatography, chelation chromatography, metal interaction chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Water Supply & Treatment (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT14709704T 2013-03-15 2014-03-13 Métodos de purificação de arn PT2970948T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361799705P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PT2970948T true PT2970948T (pt) 2019-03-20

Family

ID=50272650

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14709704T PT2970948T (pt) 2013-03-15 2014-03-13 Métodos de purificação de arn

Country Status (17)

Country Link
US (3) US11155572B2 (pt)
EP (2) EP2970948B1 (pt)
JP (1) JP6461830B2 (pt)
CN (1) CN105283548A (pt)
BR (1) BR112015023513A2 (pt)
CA (1) CA2906281A1 (pt)
CY (1) CY1121478T1 (pt)
DK (1) DK2970948T3 (pt)
ES (2) ES2720200T3 (pt)
HR (1) HRP20190197T1 (pt)
HU (1) HUE042072T2 (pt)
LT (1) LT2970948T (pt)
PL (1) PL2970948T3 (pt)
PT (1) PT2970948T (pt)
SI (1) SI2970948T1 (pt)
TR (1) TR201903248T4 (pt)
WO (1) WO2014140211A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
DK3467108T3 (da) 2013-03-14 2024-06-10 Translate Bio Inc Fremgangsmåder til oprensning af messenger-RNA
US11377470B2 (en) 2013-03-15 2022-07-05 Modernatx, Inc. Ribonucleic acid purification
SI2970948T1 (sl) * 2013-03-15 2019-04-30 Glaxosmithkline Biologicals Sa Postopki čiščenja RNA
WO2015048744A2 (en) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucleotides encoding immune modulating polypeptides
EP3052521A1 (en) 2013-10-03 2016-08-10 Moderna Therapeutics, Inc. Polynucleotides encoding low density lipoprotein receptor
RU2746406C2 (ru) 2014-04-23 2021-04-13 МОДЕРНАТиЭкс, ИНК. Вакцины на основе нуклеиновых кислот
JP6571679B2 (ja) 2014-04-25 2019-09-04 トランスレイト バイオ, インコーポレイテッド メッセンジャーrnaの精製方法
DK3294885T3 (da) 2015-05-08 2020-08-10 Curevac Real Estate Gmbh Fremgangsmåde til at fremstille rna
EP4108769B1 (en) 2015-05-29 2023-08-30 CureVac Manufacturing GmbH A method for producing and purifying rna, comprising at least one step of tangential flow filtration
WO2017025120A1 (en) 2015-08-07 2017-02-16 Curevac Ag Process for the in vivo production of rna in a host cell
WO2017083286A1 (en) 2015-11-09 2017-05-18 University Of Notre Dame Particle size purification method and devices
EA201891532A1 (ru) 2015-12-28 2019-01-31 Новартис Аг Композиции и способы лечения гемоглобинопатий
KR20190045174A (ko) * 2016-07-21 2019-05-02 스파크 테라퓨틱스, 인코포레이티드 재조합 아데노신 관련 바이러스(rAAV) 벡터를 고수율로 생산하기 위한 확장 가능한 고회수 방법 및 이에 의해 생산된 재조합 아데노-관련 바이러스(rAAV) 벡터
WO2018041921A1 (en) 2016-08-31 2018-03-08 Curevac Ag Mixing device for the production of a liquid nucleic acid composition
SG11201901941YA (en) 2016-09-14 2019-04-29 Modernatx Inc High purity rna compositions and methods for preparation thereof
US11279923B2 (en) 2016-11-28 2022-03-22 Curevac Ag Method for purifying RNA
EP3555289A1 (en) 2016-12-13 2019-10-23 ModernaTX, Inc. Rna affinity purification
TW201839136A (zh) 2017-02-06 2018-11-01 瑞士商諾華公司 治療血色素異常症之組合物及方法
IL268857B2 (en) 2017-02-27 2024-09-01 Translate Bio Inc Methods for the purification of messenger RNA
US20230064106A1 (en) 2017-05-17 2023-03-02 Curevac Real Estate Gmbh Method for determining at least one quality parameter of an rna sample
WO2018232357A1 (en) 2017-06-15 2018-12-20 Modernatx, Inc. Rna formulations
US20200325527A1 (en) 2017-08-11 2020-10-15 Glaxosmithkline Biologicals Sa Rna identity method using rnase h digestion and size fractionating
US11912982B2 (en) 2017-08-18 2024-02-27 Modernatx, Inc. Methods for HPLC analysis
EP3668977A4 (en) 2017-08-18 2021-04-21 Modernatx, Inc. HPLC ANALYTICAL PROCESSES
WO2019046809A1 (en) 2017-08-31 2019-03-07 Modernatx, Inc. METHODS OF MANUFACTURING LIPID NANOPARTICLES
TWI816721B (zh) * 2017-12-07 2023-10-01 德商Emp生物科技公司 應用徑向技術色層分析術的系統及方法
JP7352581B2 (ja) * 2018-06-28 2023-09-28 キュアバック アールエヌエイ プリンター ゲーエムベーハー Rnaインビトロ転写用バイオリアクター
CN118421617A (zh) 2018-08-24 2024-08-02 川斯勒佰尔公司 用于纯化信使rna的方法
US12090235B2 (en) 2018-09-20 2024-09-17 Modernatx, Inc. Preparation of lipid nanoparticles and methods of administration thereof
IL282368B2 (en) * 2018-10-24 2024-09-01 Hoffmann La Roche A process for the purification of oligonucleotides
WO2020160087A1 (en) * 2019-01-29 2020-08-06 Flagship Pioneering Innovations V, Inc. Methods of separating long polynucleotides from a composition
KR20210125536A (ko) * 2019-02-11 2021-10-18 에트리스 게엠베하 접선 유동 여과에 의한 mRNA 정제
WO2020257275A1 (en) * 2019-06-20 2020-12-24 Arcturus Therapeutics, Inc. Improved in vitro transcription purification platform
CN115176005A (zh) 2019-12-18 2022-10-11 诺华股份有限公司 用于治疗血红蛋白病的组合物和方法
US20240277830A1 (en) 2020-02-04 2024-08-22 CureVac SE Coronavirus vaccine
EP4107261A1 (en) * 2020-02-21 2022-12-28 Biogen MA Inc. Methods of preparing oligonucleotide compositions using ultrafiltration / diafiltration
WO2021229217A1 (en) * 2020-05-12 2021-11-18 Cranfield University A method and modular apparatus for the synthesis of rna-based therapeutics
CN111812230A (zh) * 2020-06-24 2020-10-23 南京济群生物科技有限公司 一种半定量测定dna中rna含量的sec-hplc检测方法
WO2022056466A1 (en) * 2020-09-14 2022-03-17 Mobius Biomedical, Inc. Process technology for biological product manufacturing and downstream purification
US20220364078A1 (en) * 2021-05-14 2022-11-17 Crispr Therapeutics Ag Mrna large scale synthesis and purification
WO2022266389A1 (en) * 2021-06-17 2022-12-22 Modernatx, Inc. Alternative rna purification strategies
EP4359527A2 (en) 2021-06-23 2024-05-01 Novartis AG Compositions and methods for the treatment of hemoglobinopathies
WO2023031858A1 (en) 2021-09-01 2023-03-09 Glaxosmithkline Biologicals Sa Plasmid dna purification methods
WO2023073228A1 (en) 2021-10-29 2023-05-04 CureVac SE Improved circular rna for expressing therapeutic proteins
WO2024072904A2 (en) * 2022-09-28 2024-04-04 Modernatx, Inc. Purification of nucleotides

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256294A (en) 1990-09-17 1993-10-26 Genentech, Inc. Tangential flow filtration process and apparatus
US6011148A (en) 1996-08-01 2000-01-04 Megabios Corporation Methods for purifying nucleic acids
EP0853123A1 (de) 1997-01-10 1998-07-15 Roche Diagnostics GmbH Reinigung von DNA durch Cross-Flow-Filtration
JP2002502856A (ja) * 1998-02-04 2002-01-29 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング 核酸の単離および精製方法
EP1488233A4 (en) * 2001-10-09 2006-06-21 Genentech Inc NEW ACID MUDE PROTEINS AND THESE CODING POLYNUCLEOTIDES
US8075780B2 (en) 2003-11-24 2011-12-13 Millipore Corporation Purification and concentration of synthetic biological molecules
CA2567254C (en) 2004-05-18 2012-03-13 Alphavax, Inc. Tc-83-derived alphavirus vectors, particles and methods
WO2008073620A2 (en) * 2006-11-02 2008-06-19 Neose Technologies, Inc. Manufacturing process for the production of polypeptides expressed in insect cell-lines
DE102006061015A1 (de) 2006-12-22 2008-06-26 Curevac Gmbh Verfahren zur Reinigung von RNA im präparativen Maßstab mittels HPLC
CA2766907A1 (en) 2009-07-06 2011-01-13 Novartis Ag Self replicating rna molecules and uses thereof
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
PT2590676T (pt) 2010-07-06 2016-11-04 Glaxosmithkline Biologicals Sa Partículas de transferência de tipo virião para moléculas de arn auto-replicante
EP3449910A1 (en) 2010-07-06 2019-03-06 GlaxoSmithKline Biologicals S.A. Cationic oil-in-water emulsions
ES2586580T3 (es) 2010-07-06 2016-10-17 Glaxosmithkline Biologicals Sa Inmunización de mamíferos grandes con dosis bajas de ARN
US20130189757A1 (en) * 2010-07-16 2013-07-25 Valorisation-Recherche, Limited Partnership Affinity purification of rna under native conditions based on the lambda boxb/n peptide interaction
PL4008357T3 (pl) 2010-08-31 2023-03-06 Glaxosmithkline Biologicals Sa Małe liposomy do dostarczania rna kodującego immunogen
US20130189351A1 (en) 2010-08-31 2013-07-25 Novartis Ag Lipids suitable for liposomal delivery of protein coding rna
ES2938866T3 (es) 2010-08-31 2023-04-17 Glaxosmithkline Biologicals Sa Liposomas pegilados para la administración de ARN que codifica para inmunógeno
AU2011340132A1 (en) 2010-12-10 2013-05-02 Andrew Brian Herbert Compositions for separation methods
EP2729126B1 (en) 2011-07-06 2020-12-23 GlaxoSmithKline Biologicals SA Liposomes having useful n:p ratio for delivery of rna molecules
MX350198B (es) 2011-07-06 2017-08-30 Novartis Ag Emulsiones aceite en agua que contienen acidos nucleicos.
WO2013006838A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
JP6120839B2 (ja) 2011-07-06 2017-04-26 ノバルティス アーゲー カチオン性水中油型エマルジョン
WO2013103439A1 (en) * 2012-01-06 2013-07-11 Infinity Fuel Cell And Hydrogen, Inc. Electrochemical cell with improved water or gas management
DK3467108T3 (da) 2013-03-14 2024-06-10 Translate Bio Inc Fremgangsmåder til oprensning af messenger-RNA
SI2970948T1 (sl) * 2013-03-15 2019-04-30 Glaxosmithkline Biologicals Sa Postopki čiščenja RNA

Also Published As

Publication number Publication date
EP2970948A1 (en) 2016-01-20
US20210214388A1 (en) 2021-07-15
JP6461830B2 (ja) 2019-01-30
ES2720200T3 (es) 2019-07-18
US11155572B2 (en) 2021-10-26
BR112015023513A2 (pt) 2017-07-18
EP3521429B1 (en) 2022-05-04
HRP20190197T1 (hr) 2019-04-05
US20240300994A1 (en) 2024-09-12
ES2923018T3 (es) 2022-09-22
JP2016512212A (ja) 2016-04-25
SI2970948T1 (sl) 2019-04-30
EP2970948B1 (en) 2018-12-26
CN105283548A (zh) 2016-01-27
WO2014140211A1 (en) 2014-09-18
DK2970948T3 (en) 2019-04-08
HUE042072T2 (hu) 2019-06-28
CA2906281A1 (en) 2014-09-18
US20160024139A1 (en) 2016-01-28
US12018044B2 (en) 2024-06-25
TR201903248T4 (tr) 2019-03-21
CY1121478T1 (el) 2020-05-29
PL2970948T3 (pl) 2019-06-28
LT2970948T (lt) 2019-03-25
EP3521429A1 (en) 2019-08-07

Similar Documents

Publication Publication Date Title
HRP20190197T1 (hr) Postupci pročišćavanja rna
IL246002A0 (en) New methods
IL245935A0 (en) Methods for RNA analysis
IL245639B (en) water purification
IL240215A0 (en) Methods for the purification of messenger RNA
DK2922554T3 (en) Terminalt modificeret rna
SG11201505198WA (en) Protein purification methods
GB201314217D0 (en) Coolant purification
SG11201505204VA (en) Protein purification process
HK1216429A1 (zh) 用於純化芳基硫酸酯酶 的方法
GB201300957D0 (en) Sequencing method
PL2985275T3 (pl) Sposób oczyszczania kwasu beta-hydroksy-beta-metylomasłowego
GB201306980D0 (en) Methods
HK1223111A1 (zh) 方法
ZA201603797B (en) Novel purification processes
PL2970845T3 (pl) Bioreaktor
GB201312444D0 (en) Methods
GB201209082D0 (en) Purification method
GB201308516D0 (en) Methods
GB201304234D0 (en) Methods
HK1218781A1 (zh) 方法
GB201314581D0 (en) Purification
GB201315714D0 (en) DNA Construct
GB2515553B (en) Coolant purification
EP2814499A4 (en) PURIFICATION PROCESS